Quantcast

Posts related to ‘AMLN’

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company.  It is one of the biggest public merger rumors out there. At least that is the belief ...
Read Full Story »

Amylin Gets Carl Icahn Off Its Neck! (AMLN, IEP)

Amylin Pharmaceuticals, Inc. (AMLN) is supposed to be getting a takeover offer soon, or at least it is expected to receive or disclose several possible bids soon.  Now the company ...
Read Full Story »

24/7 Wall St. Closing Bell (GE, FFIV, GRPN, PGR, REGN, CHKP, COP, DHI, ETN, HAS, PCH, XRX, AMLN, LSI)

Markets opened lower this morning following some reversals in Europe, not the least of which is the coming French presidential election. PMI readings from Europe and China were also weak. ...
Read Full Story »

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company.  With another small-cap to mid-cap biotech and ...
Read Full Story »

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer ...
Read Full Story »

Media Digest (4/5/2012) Reuters, WSJ, NYT, FT, Bloomberg

After legal issues slowed their progress last year, foreclosures are about to increase. (Reuters) Time Warner Cable (NYSE: TWC) may end its deal with Current TV because of low ratings. ...
Read Full Story »

24/7 Wall St. Closing Bell (DTV, KMI, VZ, WTW, NVDA, CBK, SNX, FDO, JOSB, MOS, RHT, SN, BBY, SHAW, CMC, AMLN, VRML)

Markets opened nearly flat this morning but took a dive early and have muddled along the rest of the day in negative territory. This morning’s report on falling durable goods ...
Read Full Story »

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN).  News from Bloomberg is out that the company has rejected an ...
Read Full Story »

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front.  The companies have announced that the European Commission has now ...
Read Full Story »

Top Analyst Upgrades & Downgrades (MO, AMZN, UHAL, AMLN, ACI, CAJ, CMCSA, DE, DLR, ENS, EQIX, INCY, LO, WFR, NWL, NVDA, PM, RENN)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Thursday morning. Altria Group Inc. (NYSE: MO) Started as Hold ...
Read Full Story »

Mid-day Movers (TNB, PBY, AMLN, GTXI, GCI)

Among the major movers at around noon today are Thomas & Betts Corp. (NYSE: TNB), Pep Boys -- Manny, Joe & Jack (NYSE: PBY), Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), GTX ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AMGN, AMLN, NLY, BAM, GBX, GMCR, HSY, LULU, M, CRM, SPR, TK, TWGP)

These are some of Monday's top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at Leerink Swann. Amylin Pharmaceuticals, Inc. ...
Read Full Story »

Media Digest (11/9/2011) Reuters, WSJ, NYTimes, FT

Greece will announce its new government today. (Reuters) Inflation in China drops in October. (Reuters) Olympus investment losses may have gone above $1 billion. (Reuters) Silvio Berlusconi leaves as prime ...
Read Full Story »

24/7 Closing Bell (BIDU, MON, T, CRUS, PLCM, PM, NOK, SCSS, RVBD, AMLN, CLWR, BWLD)

The market sure didn't feel too great through much of the warning, but the day turned out a lot better than it was looking. Weekly jobless claims remained stubbornly above ...
Read Full Story »

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

We have compiled a detailed list of expected upside in the biotech sector.  The sector has consolidated and now there is about to be a rush of earnings reports from ...
Read Full Story »